The initial focus of the company is the development of a soup and a range of other food products to reduce elevated blood glucose to ‘healthy’ levels in those at risk of Type II Diabetes (T2D). In addition to T2D, high levels of blood glucose are also a risk factor for other chronic conditions such as cardiovascular disease and some cancers. Our products are delicious and ‘healthy’ and will appeal to those with or without a health condition.
Blood glucose reduction is achieved by consuming just one portion of soup per week. The low impact on lifestyle (once weekly) and the healthy nature of the product make it an attractive meal option, particularly to those consumers who are seeking a healthy diet as well as those at risk of T2D. Neither over consumption or continued consumption of the product after the desired outcome is achieved is likely to drive blood glucose below the normal range.
The key ingredient in the soups is a unique, naturally bred broccoli. This broccoli has been developed by Professor Richard Mithen.
The company is a spin-out from the Quadram Institute Bioscience, one of the UK’s leading food and health research organisations, located at the Norwich Research Park (NRP), UK. It was formed with support from technology transfer specialists, Plant Biosciences Ltd (PBL) and the NRP translational fund before securing seed funding from the UK Innovation Science Seed Fund, Jonathan Milner and Oxford Technology Management and a grant from Innovate UK.